The US Food and Drug Administration (FDA) has approved a medicine that would reduce the risk of acquiring HIV in adult ...

The Department of Health-Center for Health Development (DOH-CHD) Caraga introduced the ABCDE to prevent the transmission of ...

While joining Gilead Sciences in welcoming the FDA's approval of a twice-yearly shot to prevent HIV, public health advocates ...

The Food and Drug Administration on Wednesday granted approval for Gilead Sciences’ twice-yearly injectable HIV prevention ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...

FORT LAUDERDALE, FL – Holy Cross Health has received a three-year grant from ViiV Positive Action Network to develop a ...

This isn't just portfolio trimming it's Masayoshi Son playing long ball in AI. The SoftBank founder is reportedly eyeing up ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Name three LGBTQ historical figures (a) with a connection to Washington, D.C., and (b) who were or are Jewish.